Cardiomyopathy Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 25, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cardiomyopathy Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02312357/Cardiomyopathy-Global-Clinical-Trials-Review-H2-2014.html

Cardiomyopathy Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Cardiomyopathy Global Clinical Trials Review, H2, 2014" provides data on the Cardiomyopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cardiomyopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cardiomyopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6

Cardiomyopathy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cardiomyopathy to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cardiomyopathy to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21

In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cardiomyopathy 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Cardiomyopathy Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Johnson & Johnson 33
Clinical Trial Overview of Johnson & Johnson 33
Gilead Sciences, Inc. 34
Clinical Trial Overview of Gilead Sciences, Inc. 34
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Les Laboratoires Servier SAS 36
Clinical Trial Overview of Les Laboratoires Servier SAS 36
Celladon Corporation 37
Clinical Trial Overview of Celladon Corporation 37
Aastrom Biosciences, Inc. 38
Clinical Trial Overview of Aastrom Biosciences, Inc. 38
Bayer AG 39
Clinical Trial Overview of Bayer AG 39
Array BioPharma Inc. 40
Clinical Trial Overview of Array BioPharma Inc. 40

AAVLife 41
Clinical Trial Overview of AAVLife 41
A. Menarini Industrie Farmaceutiche Riunite Srl 42
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 42
Clinical Trial Overview of Top Institutes / Government 43
National Heart, Lung, and Blood Institute 43
Clinical Trial Overview of National Heart, Lung, and Blood Institute 43
University of Pittsburgh 44
Clinical Trial Overview of University of Pittsburgh 44
Johns Hopkins University 45
Clinical Trial Overview of Johns Hopkins University 45
Assistance Publique - Hopitaux de Paris 46
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 46
University of Michigan 47
Clinical Trial Overview of University of Michigan 47
Osaka University 48
Clinical Trial Overview of Osaka University 48
Maastricht University Medical Center 49
Clinical Trial Overview of Maastricht University Medical Center 49
University Health Network 50
Clinical Trial Overview of University Health Network 50
Johann Wolfgang Goethe University Hospitals 51
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 51
Stanford University 52
Clinical Trial Overview of Stanford University 52
Five Key Clinical Profiles 53
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76

Source 76

List of Tables
Cardiomyopathy Therapeutics, Global, Clinical Trials by Region, 2014* 7
Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cardiomyopathy Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Cardiomyopathy Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Cardiomyopathy Therapeutics, Global, Terminated Clinical Trials, 2014* 27

Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 33
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 34
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 35
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Laboratoires Servier SAS, 2014* 36
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Celladon Corporation, 2014* 37
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2014* 38
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 39
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Array BioPharma Inc., 2014* 40
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AAVLife, 2014* 41
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2014* 42
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 43
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014* 44

Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 45
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 46
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014* 47
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2014* 48
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 49
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014* 50
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014* 51
Cardiomyopathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 52

List of Figures
Cardiomyopathy Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Cardiomyopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Cardiomyopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Cardiomyopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Cardiomyopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Cardiomyopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Cardiomyopathy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Cardiomyopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of Cardiomyopathy to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Cardiomyopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Cardiomyopathy Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Cardiomyopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Cardiomyopathy Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Cardiomyopathy Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Cardiomyopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Cardiomyopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Cardiomyopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Cardiomyopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Cardiomyopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 75

To order this report: Cardiomyopathy Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02312357/Cardiomyopathy-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker